HeartSciences

Heart Sciences

Medical Devices, 9 VLG Cir, Southlake, Texas, 76262, United States, 11-50 Employees

heartsciences.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +17*********

Who is HEARTSCIENCES

Heart disease is a global pandemic affecting 26 million worldwide and increasing in prevalence. More effective front-line tools are needed to identify patients earlier while lowering cost...

Read More

map
  • 9 VLG Cir, Southlake, Texas, 76262, United States Headquarters: 9 VLG Cir, Southlake, Texas, 76262, United States
  • 2008 Date Founded: 2008
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3845 | NAICS Code: 541810 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from HEARTSCIENCES

HeartSciences Org Chart and Mapping

Employees

Eddie Abshire

Sr. Systems Test Engineer / R&D Lab Manager

Matthew Hall

Software Verification Engineer II

Mark Hilz

Chief Operating Officer

Aaron Peterson

Vice President, Research and Development

Hank Zhang

Principal Software Engineer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding HeartSciences

Answer: HeartSciences's headquarters are located at 9 VLG Cir, Southlake, Texas, 76262, United States

Answer: HeartSciences's phone number is +17*********

Answer: HeartSciences's official website is https://heartsciences.com

Answer: HeartSciences's revenue is $10 Million to $25 Million

Answer: HeartSciences's SIC: 3845

Answer: HeartSciences's NAICS: 541810

Answer: HeartSciences has 11-50 employees

Answer: HeartSciences is in Medical Devices

Answer: HeartSciences contact info: Phone number: +17********* Website: https://heartsciences.com

Answer: Heart disease is a global pandemic affecting 26 million worldwide and increasing in prevalence. More effective front-line tools are needed to identify patients earlier while lowering costs for health systems. Current conventional ECG/EKG testing, the key front-line tool, has significant limitations for detecting 2 out of 3 categories of heart disease, ischemia (CAD) and structural heart disease. HeartSciences sits at the forefront of innovation and technological development focused on advancing the field of electrocardiology to provide early heart disease detection. WHO IS HEARTSCIENCES: HeartSciences seeks to bridge todays diagnostic gap in cardiac care by providing effective front-line solutions that assist in the detection of heart disease in at-risk patients. HeartSciences has invested heavily in research and development focused on advancing the field of electrocardiography through the use of technology to develop new algorithms focused on detecting cardiac conditions not previously available in ECG devices. Its first product, the MyoVista Wavelet ECG (wavECGTM) Cardiac Testing Device, is a resting 12-lead electrocardiograph that uses AI and continuous wavelet transform (CWT) signal processing to provide cardiac information associated with left ventricular diastolic dysfunction (LVDD), a condition which has previously not been possible to detect using conventional electrocardiology. LVDD is associated with almost all forms and co-morbidities of heart disease and may include hypertension, diabetes, valvular disease, ischemia, and reduced systolic function, among others.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access